tag:blogger.com,1999:blog-5698599151422542939.post2279519682201441883..comments2023-09-21T05:14:00.254-04:00Comments on Euvoluntary Exchange: INK DOES NOT WORK AND TASTES AWFUL. TERRIBLE PEN 1/10 WOULD NOT BUY AGAIN.Mungowitzhttp://www.blogger.com/profile/02340064320347875601noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-5698599151422542939.post-70307959526617894012016-08-29T08:52:42.029-04:002016-08-29T08:52:42.029-04:00Congratulations for being the only one I've be...Congratulations for being the only one I've been able to find who understands discriminatory pricing. Could it be any clearer than this from the WSJ;<br /><br />http://www.wsj.com/articles/mylan-to-launch-cheaper-generic-epipen-alternative-1472467730<br /><br />———–quote———-<br />Mylan NV on Monday said it would launch a generic alternative to EpiPen at a 50% discount after being criticized for dramatically raising the price of the lifesaving drug.<br /><br />The company said it would list the authorized generic—which will be identical to the branded product—for $300 per two-pack carton. Mylan said it expects to launch the generic in “several weeks,” after labeling revisions.<br /><br />….Chief Executive Heather Bresch. …said bypassing the brand system and offering an additional alternative was the best option “because of the complexity and opaqueness of today’s branded supply chain and the increased shifting of costs to patients as a result of high deductible health plans.”<br />————–endquote————–<br /><br />Oh, Obamacare!susupplyhttps://www.blogger.com/profile/14712328565035046516noreply@blogger.com